14-year hip survivorship after periacetabular osteotomy: a follow-up study on 1, 385 hips. (3rd May 2020)

• Record Type: Journal Article
• Authors: Larsen, Josefine Beck; Mechlenburg, Inger; Jakobsen, Stig Storgaard; Thilleman, Theis Munchholm; Søballe, Kjeld
• Is Part Of: Acta orthopaedica. Volume 91:Number 3(2020)
• Page Start: 299
• Page End: 305
• Publication Date: 2020-05-03
• Subjects: Orthopedics -- Periodicals; 616.7005
• DOI: 10.1080/17453674.2020.1731159
• Languages: English
• ISSNs: 1745-3674

Abstract

Abstract : Background and purpose — Few studies have evaluated the long- and mid-term outcomes after minimally invasive periacetabular osteotomy (PAO). We investigated: (1) the long-term hip survival rate after PAO; (2) the risk of complications and additional surgery after PAO; and (3) the hip function at different follow-up points. Patients and methods — We reviewed 1, 385 hips (1, 126 patients) who underwent PAO between January 2004 and December 2017. Through inquiry to the Danish National Patient Registry we identified conversions to total hip arthroplasty (THA) and complications after PAO. We evaluated the Hip disability and Osteoarthritis Outcome Score (HOOS) obtained preoperatively, and at 6 months, 2-, 5-, and 10-years' follow-up. Results — 73 of the 1, 385 hips were converted to THA. The overall Kaplan–Meier hip survival rate was 80% (95% CI 68–88) at 14 years with a mean follow-up of 5 years (0.03–14). 1.1% of the hips had a complication requiring surgical intervention. The most common additional surgery was removal of screws (13%) and 11% received a hip arthroscopy. At the 2-year follow-up, HOOS pain improved by a mean of 26 points (CI 24–28) and a HOOS pain score > 50 was observed in 86%. Interpretation — PAO preserved 4 of 5 hips at 14 years, with higher age leading to lower survivorship. The PAO technique was shown to be safe; 1.1% of patients had a complication that demanded surgical intervention. The majority of the patients with preserved hips have no or low pain. The operation is effective with a good clinical outcome.